QNTM.CSE Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)
Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
7
Frequently Asked Questions
What is Market Cap of Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)?
What is the 52-week high for Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)?
What is the 52-week low for Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)?
What is Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting) stock price today?
What was Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting) stock price yesterday?
What is the PE ratio of Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)?
What is the Price-to-Book ratio of Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)?
What is the 50-day moving average of Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)?
How many employess does Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting) has?